Skip to main content
Michael Schilsky, MD, Gastroenterology, New Haven, CT, Greenwich Hospital

MichaelLewisSchilskyMD

Gastroenterology New Haven, CT

Hepatology & Liver Transplantation

Professor, Internal Medicine, Yale University School of Medicine

Overview of Dr. Schilsky

Dr. Michael Schilsky is a gastroenterologist in New Haven, CT and is affiliated with multiple hospitals in the area, including Greenwich Hospital, Danbury Hospital, and Yale-New Haven Hospital. He received his medical degree from University of Chicago Division of the Biological Sciences The Pritzker School of Medicine and has been in practice 35 years. Dr. Schilsky accepts several types of health insurance, listed below. He is one of 25 doctors at Greenwich Hospital and one of 33 doctors at Danbury Hospital who specialize in Gastroenterology.

Education & Training

  • Montefiore Medical Center/Albert Einstein College of Medicine
    Montefiore Medical Center/Albert Einstein College of MedicineFellowship, Gastroenterology, 1985 - 1989
  • Jacobi Medical Center
    Jacobi Medical CenterResidency, Internal Medicine, 1982 - 1985
  • University of Chicago Division of the Biological Sciences The Pritzker School of Medicine
    University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1982

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 2007 - 2022
  • NY State Medical License
    NY State Medical License 1983 - 2023
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Gastroenterology
  • American Board of Internal Medicine Transplant Hepatology

Awards, Honors, & Recognition

  • Fellow American Association for the Study of Liver Disease AASLD, 2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Publications & Presentations

PubMed

Other

Press Mentions

  • Wilson Therapeutics Presents Updated Preliminary Clinical Data on WTX101 at the AASLD Liver Meeting
    Wilson Therapeutics Presents Updated Preliminary Clinical Data on WTX101 at the AASLD Liver MeetingNovember 11th, 2016
  • Wilson Therapeutics AB: Wilson Therapeutics Announces That the Ongoing Phase II Study Has Been Fully Enrolled
    Wilson Therapeutics AB: Wilson Therapeutics Announces That the Ongoing Phase II Study Has Been Fully EnrolledMay 18th, 2016
  • Liver Donation for Transplant Misunderstood, Underutilized
    Liver Donation for Transplant Misunderstood, UnderutilizedJune 21st, 2019
  • Join now to see all

Grant Support

  • Initial Therapy Of Wilson'S DiseaseNational Center For Research Resources1999–2001
  • Initial Therapy Of Wilsons DiseaseNational Center For Research Resources1999
  • Hepatic Disorders Of Heavy Metal MetabolismNational Center For Research Resources1997
  • Metallothionein And Liver Cancer In The LEC RATNational Cancer Institute1994–1997
  • Hepatic Biosynthesis Of CeruloplasminNational Institute Of Diabetes And Digestive And Kidney Diseases1989–1993
  • Copper Inhibition Of Protein Synthesis In HepatocytesNational Institute Of Diabetes And Digestive And Kidney Diseases1987–1988

Committees

  • Chair, Special Interest Group, Transplant and Surgery, AASLD 2020 - Present
  • Member, Practice Guidelines Committee, American Association for the Study of Liver Diseases (AASLD) 2016 - 2018

Professional Memberships

  • American Association for the Study of Liver Disease
    Fellow
  • American Society for Transplantation
    Member

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    BCBS Blue Card PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Connecticare FlexPOS
    GHI PPO
    Great West PPO
    Humana ChoiceCare Network PPO
    Multiplan PHCS PPO
    Multiplan PPO
    Oxford Health Freedom
    Oxford Health Liberty
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment